JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 卷:63 |
Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction | |
Article | |
Pizarro, Gonzalo1,2  Fernandez-Friera, Leticia1,3  Fuster, Valentin1,4  Fernandez-Jimenez, Rodrigo1,5  Garcia-Ruiz, Jose M.1,6  Garcia-Alvarez, Ana1,7  Mateos, Alonso8  Barreiro, Maria V.9  Escalera, Noemi1  Rodriguez, Maite D.1  de Miguel, Antonio10  Garcia-Lunar, Ines1,2,11  Parra-Fuertes, Juan J.12  Sanchez-Gonzalez, Javier1,13  Pardillos, Luis8  Nieto, Beatriz10  Jimenez, Adriana14  Abejon, Raquel8  Bastante, Teresa15  Martinez de Vega, Vicente2  Cabrera, Jose A.2  Lopez-Melgar, Beatriz1,12  Guzman, Gabriela1,16  Garcia-Prieto, Jaime1  Mirelis, Jesus G.1,11  Luis Zamorano, Jose5  Albarran, Agustin12  Goicolea, Javier11  Escaned, Javier1,5  Pocock, Stuart1,17  Iniguez, Andres10  Fernandez-Ortiz, Antonio1,5  Sanchez-Brunete, Vicente8  Macaya, Carlos5  Ibanez, Borja1,5  | |
[1] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid 28029, Spain | |
[2] Univ Europea Madrid, Hosp Univ Quiron, Madrid, Spain | |
[3] Hosp Monteprincipe, Madrid, Spain | |
[4] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA | |
[5] Hosp Clin San Carlos, Madrid, Spain | |
[6] Hosp Univ Cent Asturias, Oviedo, Spain | |
[7] Hosp Clin Barcelona, Barcelona, Spain | |
[8] Serv Urgencia Med Madrid SUMMA 112, Madrid, Spain | |
[9] Serv Emergencia Med 061 Galicia, Galicia, Spain | |
[10] Complejo Hosp Univ Vigo Meixoeiro, Pontevedra, Spain | |
[11] Hosp Univ Puerta de Hierro, Madrid, Spain | |
[12] Hosp Univ Doce Octubre, Madrid, Spain | |
[13] Philips Healthcare, Madrid, Spain | |
[14] Hosp Univ Leon, Leon, Spain | |
[15] Hosp Princesa, Madrid, Spain | |
[16] Hosp Univ La Paz, Madrid, Spain | |
[17] London Sch Hyg & Trop Med, London WC1, England | |
关键词: beta-adrenergic receptors; heart failure; ICD; infarct size; LVEF; magnetic resonance imaging; metoprolol; myocardial infarction; PCI; STEMI; | |
DOI : 10.1016/j.jacc.2014.03.014 | |
来源: Elsevier | |
【 摘 要 】
Objectives The goal of this trial was to study the long-term effects of intravenous (IV) metoprolol administration before reperfusion on left ventricular (LV) function and clinical events. Background Early IV metoprolol during ST-segment elevation myocardial infarction (STEMI) has been shown to reduce infarct size when used in conjunction with primary percutaneous coronary intervention (pPCI). Methods The METOCARD-CNIC (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) trial recruited 270 patients with KilliP =class <= II anterior STEMI presenting early after symptom onset (< 6 h) and randomized them to pre-reperfusion IV metoprolol or control group. Long-term magnetic resonance imaging (MRI) was performed on 202 patients (101 per group) 6 months after STEMI. Patients had a minimal 12-month clinical follow-up. Results Left ventricular ejection fraction (LVEF) at the 6 months MRI was higher after IV metoprolol (48.7 +/- 9.9% vs. 45.0 +/- 11.7% in control subjects; adjusted treatment effect 3.49%; 95% confidence interval [ CI]: 0.44% to 6.55%; P = 0.025). The occurrence of severely depressed LVEF (+/- 35%) at 6 months was significantly lower in patients treated with IV metoprolol (11% vs. 27%, P = 0.006). The proportion of patients fulfilling Class I indications for an implantable cardioverter-defibrillator (ICD) was significantly lower in the IV metoprolol grouP =(7% vs. 20%, P = 0.012). At a median follow-uP =of 2 years, occurrence of the pre-specified composite of death, heart failure admission, reinfarction, and malignant arrhythmias was 10.8% in the IV metoprolol grouP =versus 18.3% in the control group, adjusted hazard ratio (HR): 0.55; 95% CI: 0.26 to 1.04; P = 0.065. Heart failure admission was significantly lower in the IV metoprolol grouP =(HR: 0.32; 95% CI: 0.015 to 0.95; P = 0.046). Conclusions In patients with anterior KilliP =class <= II STEMI undergoing pPCI, early IV metoprolol before reperfusion resulted in higher long-term LVEF, reduced incidence of severe LV systolic dysfunction and ICD indications, and fewer heart failure admissions. (Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial; NCT01311700) (C) 2014 by the American College of Cardiology Foundation
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_j_jacc_2014_03_014.pdf | 275KB | download |